Purple Biotech (PPBT) Other Operating Expenses (2017 - 2022)

Purple Biotech (PPBT) has 6 years of Other Operating Expenses data on file, last reported at -$53000.0 in Q2 2022.

• Other Operating Expenses for Q2 2022 came in at -$53000.0, up 13.11% year-over-year; the trailing twelve-month figure through Mar 2023 was -$53000.0 (down 101.76% YoY), and the FY2025 annual result was $20.3 million, up 126643.75% from the prior year.
• Other Operating Expenses retreated to -$53000.0 in Q2 2022 per PPBT's latest filing, from $3.0 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $3.0 million in Q4 2021 and troughed at -$775000.0 in Q4 2018.
• A 5-year average of $235000.0 and a median of -$57000.0 in 2021 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2018 and 2021: Other Operating Expenses plunged 120.02% in 2018, then surged 2184.62% in 2021.
• A 5-year view of Other Operating Expenses shows it stood at -$775000.0 in 2018, then surged by 67.74% to -$250000.0 in 2019, then jumped by 42.8% to -$143000.0 in 2020, then surged by 2184.62% to $3.0 million in 2021, then plunged by 101.78% to -$53000.0 in 2022.
• Business Quant data shows PPBT's Other Operating Expenses at -$53000.0 in Q2 2022, $3.0 million in Q4 2021, and $91000.0 in Q3 2021.